Equities

Airway Medix SA

Airway Medix SA

Actions
  • Price (EUR)0.0371
  • Today's Change-0.001 / -1.33%
  • Shares traded--
  • 1 Year change-14.71%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 07:20 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of PLN
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments5.435.405.07
Total Receivables, Net1.030.273.65
Total Inventory------
Prepaid expenses------
Other current assets, total------
Total current assets6.465.678.72
Property, plant & equipment, net00.130
Goodwill, net------
Intangibles, net0039
Long term investments------
Note receivable - long term------
Other long term assets0.390.020
Total assets7.366.2149
LIABILITIES
Accounts payable1.113.8311
Accrued expenses1.170.690.29
Notes payable/short-term debt000
Current portion long-term debt/capital leases147.7913
Other current liabilities, total0.480.050.09
Total current liabilities171224
Total long term debt06.800
Total debt141513
Deferred income tax0.510.390.36
Minority interest------
Other liabilities, total2.821.831.47
Total liabilities212126
SHAREHOLDERS EQUITY
Common stock212020
Additional paid-in capital1.171.171.17
Retained earnings (accumulated deficit)(35)(36)1.30
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total--0.00--
Total equity(13)(15)22
Total liabilities & shareholders' equity7.366.2149
Total common shares outstanding615858
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.